TMCnet News
GBS Inc. to Present at the H.C. Wainwright Global Investment ConferenceNEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that, today announced that Dr. Steven Boyages, GBS’ interim CEO and Chairman of the Board, along with other management team members will participate at the H.C. Wainwright Global Investment Conference being held May 23–26, 2022 and invites investors to participate via virtual one-on-one meetings. Please see additional details below: H.C. Wainwright Global Investment Conference (Hybrid Conference) If you have interest in participating in the H.C. Wainwright Global Investment Conference, please reach out to your representative or register at the HCW events website. About GBS Inc. Company Contact: Investor Contact: |